Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsStem CellsMyeloablative AgonistsBusulfanGraft vs Host DiseaseHematopoietic Stem CellsTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCytarabineCord Blood Stem Cell TransplantationHodgkin DiseaseDisease-Free SurvivalWhole-Body IrradiationTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsSurvival RateTime FactorsSurvival AnalysisInfectionLymphoma, T-CellDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneVidarabineBlood Cell CountRecombinant ProteinsFollow-Up StudiesLeukemiaAntineoplastic AgentsBone Marrow PurgingBlood CellsEmbryonic Stem CellsLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAdult Stem CellsMesenchymal Stem Cell TransplantationMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousLymphocyte DepletionLiver TransplantationBone MarrowT-LymphocytesCell SeparationLeukocytes, MononuclearHematologic DiseasesPluripotent Stem CellsHistiocytosis, Non-Langerhans-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaOpportunistic InfectionsLivedo ReticularisFlow CytometryCell DifferentiationHLA Antigens